Skip to main content
SpringerLink
Log in

Gimeracil/oteracil/tegafur/paclitaxel

Hair loss, rash and pigmentation: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Oneyama M, et al. A long-surviving patient with unresectable advanced gastric cancer treated with S-1 and biweekly paclitaxel combination chemotherapy as second-line treatment. [Japanese]. Gan to Kagaku Ryoho 39: 1131-1133, No. 7, Jul 2012 [Japanese; summarised from a translation] - Japan

    PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gimeracil/oteracil/tegafur/paclitaxel. Reactions Weekly 1606, 76 (2016). https://doi.org/10.1007/s40278-016-18480-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-016-18480-y

Search

Navigation